| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | CORSICANTO LTD | 15,000,000 | 12,103,000 | 0.13% | PRN | |
| 52 | XENCOR INC COM | 872,072 | 11,703,000 | 0.12% | ||
| 53 | DERMA SCIENCES ORD | 3,752,390 | 11,632,000 | 0.12% | ||
| 54 | OMEROS CORP | 749,250 | 11,493,000 | 0.12% | ||
| 55 | EXELIXIS INC | 2,580,000 | 10,320,000 | 0.11% | ||
| 56 | DIMENSION THERAPEUTICS INC | 1,251,881 | 9,802,000 | 0.10% | ||
| 57 | GLOBAL BLOOD THERAPEUTICS INCORPORATED | 600,000 | 9,516,000 | 0.10% | ||
| 58 | Ascendis Pharma | 505,521 | 9,377,000 | 0.10% | ||
| 59 | ZOGENIX INC | 1,000,000 | 9,240,000 | 0.10% | ||
| 60 | ALCOBRA LTD | 2,336,359 | 8,855,000 | 0.09% | ||
| 61 | ALKERMES PLC | 250,251 | 8,556,000 | 0.09% | ||
| 62 | Life Technologies Corp | 2,137,606 | 8,422,000 | 0.09% | ||
| 63 | LIGAND PHARMACEUTICALS INC | 73,386 | 7,859,000 | 0.08% | ||
| 64 | ULTRAGENYX PHARMACEUTICAL INC COM | 123,894 | 7,844,000 | 0.08% | ||
| 65 | SAGE THERAPEUTICS INC | 224,048 | 7,183,000 | 0.08% | ||
| 66 | MACROGENICS INC | 363,676 | 6,819,000 | 0.07% | ||
| 67 | CONCERT PHARMACEUTICALS INCORPORATED | 495,908 | 6,774,000 | 0.07% | ||
| 68 | ProQR Therapeutics NV | 1,349,719 | 6,587,000 | 0.07% | ||
| 69 | CATALYST PHARMACEUTICALS INC | 5,498,459 | 6,433,000 | 0.07% | ||
| 70 | DERMIRA INC COM | 275,000 | 5,687,000 | 0.06% | ||
| 71 | AKARI THERAPEUTICS PLC | 395,882 | 5,542,000 | 0.06% | ||
| 72 | LION BIOTECHNOLOGIES INC COM | 1,066,285 | 5,417,000 | 0.06% | ||
| 73 | ENDOCYTE INC | 1,695,865 | 5,257,000 | 0.06% | ||
| 74 | ARROWHEAD PHARMACEUTICALS IN | 1,009,509 | 4,866,000 | 0.05% | ||
| 75 | NEURODERM LTD | 305,000 | 4,307,000 | 0.05% | ||
| 76 | Natera, Inc. | 450,000 | 4,284,000 | 0.05% | ||
| 77 | VITAE PHARMACEUTICALS INC | 637,597 | 4,227,000 | 0.04% | ||
| 78 | IGNYTA INC COM | 571,000 | 3,866,000 | 0.04% | ||
| 79 | LOXO ONCOLOGY INC COM | 137,735 | 3,766,000 | 0.04% | ||
| 80 | TREVENA INC | 450,000 | 3,722,000 | 0.04% | ||
| 81 | AERIE PHARMACEUTICALS INC COM | 299,356 | 3,640,000 | 0.04% | ||
| 82 | AIMMUNE THERAPEUTICS INC COM | 250,000 | 3,390,000 | 0.04% | ||
| 83 | MEDGENICS INC | 765,000 | 3,366,000 | 0.04% | ||
| 84 | SERES THERAPEUTICS INC | 125,000 | 3,320,000 | 0.04% | ||
| 85 | Curis, Inc | 1,999,303 | 3,219,000 | 0.03% | ||
| 86 | ADR - Nabriva Therapeutics AG- Usd | 350,000 | 3,136,000 | 0.03% | ||
| 87 | JUNO THERAPEUTICS INC COM | 80,000 | 3,047,000 | 0.03% | ||
| 88 | OSIRIS THERAPEUTICS INC NEW COM | 499,193 | 2,850,000 | 0.03% | ||
| 89 | EPIZYME INC COM | 232,481 | 2,818,000 | 0.03% | ||
| 90 | INVIVO THERAPEUTICS HLDGS CORPORATION COM NEW | 400,000 | 2,792,000 | 0.03% | ||
| 91 | UNIQURE NV | 230,000 | 2,732,000 | 0.03% | ||
| 92 | ADAMAS PHARMACEUTICALS INC | 172,630 | 2,496,000 | 0.03% | ||
| 93 | Sunesis Pharmaceuticals I | 4,450,000 | 2,403,000 | 0.03% | ||
| 94 | ARRAY BIOPHARMA INC 3 06/01/2020 | 3,000,000 | 2,382,000 | 0.03% | PRN | |
| 95 | PROTALIX BIOTHERAPEUTICS INC | 3,423,000 | 2,334,000 | 0.02% | PRN | |
| 96 | IONIS PHARMACEUTICALS INC COM | 57,140 | 2,314,000 | 0.02% | ||
| 97 | Proteon Therapeutics Inc | 298,591 | 2,311,000 | 0.02% | ||
| 98 | ENANTA PHARMACEUTICALS INC | 75,357 | 2,213,000 | 0.02% | ||
| 99 | AURINIA PHARMACEUTICALS INC | 711,499 | 2,082,000 | 0.02% | ||
| 100 | TRILLIUM THERAPEUTICS INC | 211,792 | 1,959,000 | 0.02% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-102596, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
